We observed a trend toward higher OPN3 immunohistochemical staining scores from begin JMN to malignant ALMs to ILNMs, which first indicated to us that OPN3 is a significant association with progression and metastasis of ALMs. The gene discussed is OPN3; the disease is Alstrom syndrome.